ANOQUAN
|
6505-01-318-0943
|
And Caf Acetaminophen Butalbital |
Hauck W E Inc
|
|
Quote
|
NDC04379-0343-06
|
6505-01-318-0943
|
And Caf Acetaminophen Butalbital |
Hauck W E Inc
|
|
Quote
|
TOBRA-DEX
|
6505-01-318-1529
|
Tobramycin And Dexamethasone Oph |
Alcon Laboratories, Inc.
|
|
Quote
|
TOBRA-DEX EYE DROPS
|
6505-01-318-1529
|
Tobramycin And Dexamethasone Oph |
Alcon Laboratories, Inc.
|
|
Quote
|
NDC00065-0647-25
|
6505-01-318-1529
|
Tobramycin And Dexamethasone Oph |
Alcon Laboratories, Inc.
|
|
Quote
|
NDC24208-0295-25
|
6505-01-318-1529
|
Tobramycin And Dexamethasone Oph |
Bausch & Lomb Pharmaceuticals
|
|
Quote
|
NDC24208-0295-25
|
6505-01-318-1529
|
Tobramycin And Dexamethasone Oph |
Valeant Pharmaceuticals
|
|
Quote
|
NDC61314-0647-35
|
6505-01-318-1529
|
Tobramycin And Dexamethasone Oph |
Sandoz Inc.
|
|
Quote
|
NDC00065-0648-35
|
6505-01-318-1530
|
Tobramycin And Dexamethasone Oph |
Veterans Health
|
|
Quote
|
TOBRA-DEX OINTMENT
|
6505-01-318-1530
|
Tobramycin And Dexamethasone Oph |
Alcon Laboratories, Inc.
|
|
Quote
|
TOBRA-DEX
|
6505-01-318-1530
|
Tobramycin And Dexamethasone Oph |
Alcon Laboratories, Inc.
|
|
Quote
|
NDC00065-0648-35
|
6505-01-318-1530
|
Tobramycin And Dexamethasone Oph |
Alcon Laboratories, Inc.
|
|
Quote
|
NDC00065-0648-35
|
6505-01-318-1530
|
Tobramycin And Dexamethasone Oph |
Cardinal Health 100 Inc
|
|
Quote
|
NDC00904-0053-00
|
6505-01-318-1565
|
Dextromethorphan Hydrobromide An |
Major Pharmaceuticals Inc
|
|
Quote
|
NDC00904-0053-20
|
6505-01-318-1565
|
Dextromethorphan Hydrobromide An |
Major Pharmaceuticals Inc
|
|
Quote
|
NDC55532-0600-08
|
6505-01-318-1866
|
Dextromethorphan Hydrobromide An |
Ion Laboratories Inc
|
|
Quote
|
6984-46
|
6505-01-318-1867
|
Moistur Skin Protective Ointment |
Convatec
|
|
Quote
|
OMNIPAQUE 350
|
6505-01-318-2947
|
Iohexol Injection |
Sanofi-synthelabo Inc
|
|
Quote
|
NDC00024-1414-03
|
6505-01-318-2947
|
Iohexol Injection |
Sanofi-synthelabo Inc
|
|
Quote
|
NDC00074-9789-03
|
6505-01-318-5720
|
Fat Emulsion Injection |
Abbott Laboratories Inc.
|
|
Quote
|
LIPOSYN II
|
6505-01-318-5720
|
Fat Emulsion Injection |
Abbott Laboratories Inc.
|
|
Quote
|
LIPOSYN II 20%
|
6505-01-318-5720
|
Fat Emulsion Injection |
Abbott Laboratories Inc.
|
|
Quote
|
NDC00074-9789-03
|
6505-01-318-5720
|
Fat Emulsion Injection |
Abbott Laboratories Inc
|
|
Quote
|
NDC00074-9789-03
|
6505-01-318-5720
|
Fat Emulsion Injection |
Abbott Laboratories
|
|
Quote
|
K-DUR
|
6505-01-318-5737
|
Potassium Chloride Extended-rele |
Schering-plough Corporation
|
|
Quote
|
NDC00085-0787-06
|
6505-01-318-5737
|
Potassium Chloride Extended-rele |
Schering-plough Corporation
|
|
Quote
|
ANAFRANIL
|
6505-01-318-7398
|
Clomipramine Hydrochloride Capsu |
Ciba-geigy Corp
|
|
Quote
|
ANAFRANIL CAPSULES
|
6505-01-318-7398
|
Clomipramine Hydrochloride Capsu |
Ciba-geigy Corp
|
|
Quote
|
NDC00378-3025-01
|
6505-01-318-7398
|
Clomipramine Hydrochloride Capsu |
Mylan Pharmaceuticals Inc
|
|
Quote
|
NDC00093-0956-01
|
6505-01-318-7398
|
Clomipramine Hydrochloride Capsu |
Lemmon Co
|
|
Quote
|
NDC00781-2027-01
|
6505-01-318-7398
|
Clomipramine Hydrochloride Capsu |
Geneva Pharmaceuticals Inc
|
|
Quote
|
NDC58887-0115-30
|
6505-01-318-7398
|
Clomipramine Hydrochloride Capsu |
Ciba-geigy Corp
|
|
Quote
|
ANAFRANIL
|
6505-01-318-7399
|
Clomipramine Hydrochloride Capsu |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
ANAFRANIL CAPSULES
|
6505-01-318-7399
|
Clomipramine Hydrochloride Capsu |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
NDC00078-0316-05
|
6505-01-318-7399
|
Clomipramine Hydrochloride Capsu |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
ANAFRANIL
|
6505-01-318-7399
|
Clomipramine Hydrochloride Capsu |
Ciba-geigy Corp
|
|
Quote
|
ANAFRANIL CAPSULES
|
6505-01-318-7399
|
Clomipramine Hydrochloride Capsu |
Ciba-geigy Corp
|
|
Quote
|
NDC58887-0115-32
|
6505-01-318-7399
|
Clomipramine Hydrochloride Capsu |
Ciba-geigy Corp
|
|
Quote
|
NDC00078-0317-05
|
6505-01-318-7400
|
Clomipramine Hydrochloride Capsu |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
NDC58887-0116-30
|
6505-01-318-7400
|
Clomipramine Hydrochloride Capsu |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
ANAFRANIL
|
6505-01-318-7402
|
Clomipramine Hydrochloride Capsu |
Ciba-geigy Corp
|
|
Quote
|
ANAFRANIL CAPSULES
|
6505-01-318-7402
|
Clomipramine Hydrochloride Capsu |
Ciba-geigy Corp
|
|
Quote
|
NDC58887-0117-30
|
6505-01-318-7402
|
Clomipramine Hydrochloride Capsu |
Ciba-geigy Corp
|
|
Quote
|
NDC52544-0596-01
|
6505-01-318-7402
|
Clomipramine Hydrochloride Capsu |
Watson Labs Inc
|
|
Quote
|
NDC51672-4013-01
|
6505-01-318-7402
|
Clomipramine Hydrochloride Capsu |
Taro Pharmaceuticals Usa Inc
|
|
Quote
|
NDC00781-2047-01
|
6505-01-318-7402
|
Clomipramine Hydrochloride Capsu |
Sandoz Inc.
|
|
Quote
|
NDC00406-9908-01
|
6505-01-318-7402
|
Clomipramine Hydrochloride Capsu |
Mallinckrodt Inc
|
|
Quote
|
NDC00378-3075-01
|
6505-01-318-7402
|
Clomipramine Hydrochloride Capsu |
Mylan Pharmaceuticals Inc
|
|
Quote
|
NDC00093-0960-01
|
6505-01-318-7402
|
Clomipramine Hydrochloride Capsu |
Lemmon Co
|
|
Quote
|
NDC00781-2047-01
|
6505-01-318-7402
|
Clomipramine Hydrochloride Capsu |
Bristol-myers Co
|
|
Quote
|
NDC00093-0796-01
|
6505-01-318-7402
|
Clomipramine Hydrochloride Capsu |
Lemmon Co
|
|
Quote
|
2G3535
|
6505-01-318-7405
|
Usp Ceftazidime Injection |
Baxter Healthcare Corporation
|
|
Quote
|
FORTAZ
|
6505-01-318-7405
|
Usp Ceftazidime Injection |
Glaxo Wellcome Inc
|
|
Quote
|
NDC00173-0412-00
|
6505-01-318-7405
|
Usp Ceftazidime Injection |
Glaxo Wellcome Inc
|
|
Quote
|
2G3535
|
6505-01-318-7405
|
Usp Ceftazidime Injection |
Baxter Healthcare Corp
|
|
Quote
|
FORTAZ
|
6505-01-318-7405
|
Usp Ceftazidime Injection |
Baxter Healthcare Corp
|
|
Quote
|
FORTAZ INJECTION PREMIXED
|
6505-01-318-7405
|
Usp Ceftazidime Injection |
Baxter Healthcare Corp
|
|
Quote
|
NDC00173-0412-00
|
6505-01-318-7405
|
Usp Ceftazidime Injection |
Baxter Healthcare Corp
|
|
Quote
|
NDC00173-0412-00
|
6505-01-318-7405
|
Usp Ceftazidime Injection |
Baxter Healthcare Corporation
|
|
Quote
|
NDC00182-3064-62
|
6505-01-318-7461
|
Triamcinolone Diacetate Suspensi |
Goldline Laboratories Inc.
|
|
Quote
|
A90D026
|
6505-01-318-7683
|
Artificial Tears Solution |
Department of the Army
|
|
Quote
|
F90E318
|
6505-01-318-7683
|
Artificial Tears Solution |
Air Force Medical Logistics Office
|
|
Quote
|
CELLUVISC
|
6505-01-318-7683
|
Artificial Tears Solution |
Allergan Inc
|
|
Quote
|
NDC00023-4554-30
|
6505-01-318-7683
|
Artificial Tears Solution |
Allergan Inc
|
|
Quote
|
004554
|
6505-01-318-7683
|
Artificial Tears Solution |
Allergan Inc
|
|
Quote
|
CARDIZEM
|
6505-01-318-8558
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
CARDIZEM TABLETS
|
6505-01-318-8558
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
NDC00088-1772-42
|
6505-01-318-8558
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
CARDIZEM
|
6505-01-318-8559
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
CARDIZEM TABLETS
|
6505-01-318-8559
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
NDC00088-1791-42
|
6505-01-318-8559
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
ZOLADEX
|
6505-01-318-9364
|
Goserelin Acetate Implant |
Ici Americas Inc
|
|
Quote
|
ZOLADEX INJECTION
|
6505-01-318-9364
|
Goserelin Acetate Implant |
Ici Americas Inc
|
|
Quote
|
NDC00310-0960-36
|
6505-01-318-9364
|
Goserelin Acetate Implant |
Ici Americas Inc
|
|
Quote
|
NDC00310-0950-36
|
6505-01-318-9364
|
Goserelin Acetate Implant |
Astrazeneca Lp
|
|
Quote
|
SYNAREL
|
6505-01-318-9365
|
Nafarelin Acetate Nasal Solution |
Syntex Laboratories Inc
|
|
Quote
|
NDC00025-0166-08
|
6505-01-318-9365
|
Nafarelin Acetate Nasal Solution |
Pharmacia & Upjohn Inc
|
|
Quote
|
NDC00025-0166-08
|
6505-01-318-9365
|
Nafarelin Acetate Nasal Solution |
Syntex Laboratories Inc
|
|
Quote
|
NDC00025-0166-08
|
6505-01-318-9365
|
Nafarelin Acetate Nasal Solution |
Pharmacia & Upjohn Company
|
|
Quote
|
NDC00033-2260-40
|
6505-01-318-9365
|
Nafarelin Acetate Nasal Solution |
Syntex Laboratories Inc
|
|
Quote
|
NDC00025-0166-10
|
6505-01-318-9365
|
Nafarelin Acetate Nasal Solution |
Syntex Laboratories Inc
|
|
Quote
|
NDC59772-7046-40
|
6505-01-318-9375
|
Usp Captopril Tablets |
Bristol-myers Co
|
|
Quote
|
RENU
|
6505-01-318-9377
|
Contact Lens Lubricating And Rew |
Bausch and Lomb
|
|
Quote
|
RENU REWETTING DROPS
|
6505-01-318-9377
|
Contact Lens Lubricating And Rew |
Bausch and Lomb
|
|
Quote
|
F90D057
|
6505-01-318-9377
|
Contact Lens Lubricating And Rew |
Air Force Medical Logistics Office
|
|
Quote
|
625208
|
6505-01-318-9377
|
Contact Lens Lubricating And Rew |
Bausch and Lomb
|
|
Quote
|
NDC00075-0200-68
|
6505-01-318-9418
|
Usp Theophylline Capsules |
Rorer William H Inc
|
|
Quote
|
SLO-BID GYROCAPS
|
6505-01-318-9418
|
Usp Theophylline Capsules |
Rorer William H Inc
|
|
Quote
|
404
|
6505-01-319-2816
|
Surgical Detergent |
Ballard Medical Products
|
|
Quote
|
TRANDATE
|
6505-01-319-5117
|
Labetalol Hydrochloride Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
NORMODYNE
|
6505-01-319-5117
|
Labetalol Hydrochloride Tablets |
Schering-plough Corporation
|
|
Quote
|
NDC00085-0752-08
|
6505-01-319-5117
|
Labetalol Hydrochloride Tablets |
Schering-plough Corporation
|
|
Quote
|
NDC00185-0117-01
|
6505-01-319-5117
|
Labetalol Hydrochloride Tablets |
Eon Labs Inc.
|
|
Quote
|
NDC60976-0347-47
|
6505-01-319-5117
|
Labetalol Hydrochloride Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
NDC65483-0392-10
|
6505-01-319-5117
|
Labetalol Hydrochloride Tablets |
Prometheus Laboratories Inc.
|
|
Quote
|
NDC65483-0392-22
|
6505-01-319-5117
|
Labetalol Hydrochloride Tablets |
Prometheus Laboratories Inc.
|
|
Quote
|
NDC00172-4365-60
|
6505-01-319-5117
|
Labetalol Hydrochloride Tablets |
Zenith Laboratories Inc
|
|
Quote
|
NDC00677-1702-01
|
6505-01-319-5117
|
Labetalol Hydrochloride Tablets |
Baxter Healthcare Corp
|
|
Quote
|
NDC00591-0606-01
|
6505-01-319-5117
|
Labetalol Hydrochloride Tablets |
Danbury Pharmacal Inc
|
|
Quote
|
NDC51079-0929-20
|
6505-01-319-5117
|
Labetalol Hydrochloride Tablets |
Mylan Institutional Inc.
|
|
Quote
|
NDC00173-0347-47
|
6505-01-319-5117
|
Labetalol Hydrochloride Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
NDC53489-0355-01
|
6505-01-319-5117
|
Labetalol Hydrochloride Tablets |
Mutual Pharmaceutical Company, Inc.
|
|
Quote
|